对化学建模方法的洞察:评估基于刚性-灵活模型分子的配体-蛋白质结合热力学
Igor V Komarov1,2, Volodymyr A Bugrov1, Anton Cherednychenko1,2
1Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv, 01601, Ukraine.
概括
模型化合物简化了研究蛋白质 - 配体结合 (PLB) 热力学. 战略设计揭示了对力-力补偿的洞察力,通过优化连接体灵活性来帮助药物设计.
科学领域:
- 化学 化学 化学
- 生物化学 生化学
- 计算化学的计算化学
背景情况:
- 模型化合物对于研究复杂的化学相互作用至关重要.
- 蛋白质 - 连接体结合 (PLB) 热力学,包括体和体贡献,提出了重大预测挑战.
- 了解PLB对于药物化学和药物设计至关重要.
研究的目的:
- 审查研究蛋白质 - 配体结合热力学的建模方法.
- 在PLB研究中,以示范形式受约束/灵活模型分子的使用.
- 展示战略模型分子设计如何有助于理解热力学参数.
主要方法:
- 采用两对结构约束和灵活的模型分子.
- 分析模型分子的战略设计如何影响热力学参数.
- 审查现有的蛋白质 - 配体结合模型研究.
主要成果:
- 刚性化连接体可以导致结合和的补偿变化.
- 战略设计的模型分子减少了变量,为PLB热力学提供了更深入的见解.
- 新兴的"经验规则"指导着联体的设计,以最大限度地减少-补偿.
结论:
- 模型化合物是剖析复杂蛋白质-连接体相互作用的有效工具.
- 对和补偿的洞察力对于药物发现中高效的配体设计至关重要.
- 这种方法提高了对药物化学应用的结合热力学的理解.
相关概念视频
The Equilibrium Binding Constant and Binding Strength
13.0K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.0K
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Molecular Models
38.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.5K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
49
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
49
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


